Discovery shows existing drugs can treat virus
A team of researchers from Florida State University, Johns Hopkins University and the National Institutes of Health has found existing drug compounds that can both stop Zika from replicating in the body and from damaging the crucial fetal brain cells that lead to birth defects in newborns.
One of the drugs is already on the market as a treatment for tapeworm.
“We focused on compounds that have the shortest path to clinical use,” said FSU Professor of Biological Science Hengli Tang. “This is a first step toward a therapeutic that can stop transmission of this disease.”
Tang, along with Johns Hopkins Professors Guo-Li Ming and Hongjun Song and National Institutes of Health scientist Wei Zheng identified two different groups of compounds that could potentially be used to treat Zika — one that stops the virus from replicating and the other that stops the virus from killing fetal brain cells, also called neuroprogenitor cells.
One of the identified compounds is the basis for a drug called Nicolsamide, a U.S. Food and Drug Administration approved drug that showed no danger to pregnant women in animal studies. It is commonly used to treat tapeworm.
This could be prescribed by a doctor today, though tests are still needed to determine a specific treatment regimen for the infection.
Their work is outlined in an article published Monday by Nature Medicine.
Though the Zika virus was discovered in 1947, there was little known about how it worked and its potential health implications — especially among pregnant women — until an outbreak occurred in South America last year. In the United States, there have been 529 cases of pregnant women contracting Zika, though most of those are travel related. As of Aug. 24, there have been 42 of locally transmitted cases in Florida.
The virus, among other diseases, can cause microcephaly in fetuses leading them to be born with severe birth defects.
“It’s so dramatic and irreversible,” Tang said. “The probability of Zika-induced microcephaly occurring doesn’t appear to be that high, but when it does, the damage is horrible.”
Researchers around the world have been feverishly working to better understand the disease — which can be transmitted both by mosquito bite and through a sexual partner — and also to develop medical treatments.
Tang, Ming and Song first met in graduate school 20 years ago and got in contact in January because Tang, a virologist, had access to the virus and Ming and Song, neurologists, had cortical stem cells that scientists needed to test.
The group worked at a breakneck pace with researchers from Ming and Song’s lab, traveling back and forth between Baltimore and Tang’s lab in Tallahassee where they had infected the cells with the virus.
In early March, the group was the first team to show that Zika indeed caused cellular phenotypes consistent with microcephaly, a severe birth defect where babies are born with a much smaller head and brain than normal.
They immediately delved into follow-up work and teamed with NIH’s Zheng, an expert on drug compounds, to find potential treatments for the disease.
Researchers screened 6,000 compounds that were either already approved by the FDA or were in the process of a clinical trial because they could be made more quickly available to people infected by Zika.
“It takes years if not decades to develop a new drug,” Song said. “In this sort of global health emergency, we don’t have time. So instead of using new drugs, we chose to screen existing drugs. In this way, we hope to create a therapy much more quickly.”
All of the researchers are continuing the work on the compounds and hope to begin testing the drugs on animals infected with Zika in the near future.
Learn more: FSU research team makes Zika drug breakthrough
The Latest on: Zika
via Google News
The Latest on: Zika
- At epicenter of Zika outbreak, dengue immunity provided protection on February 7, 2019 at 12:31 pm
New Haven, Conn. -- When the Zika virus arrived in the Americas in early 2015, it struck hard, infecting 73% of people in one Brazilian community at the epicenter of the pandemic, according to a new s... […]
- Prior dengue infection may protect against Zika: study on February 7, 2019 at 11:31 am
CHICAGO (Reuters) - Prior infection with dengue, a mosquito-borne disease that infects nearly 400 million people a year, could reduce the risk of contracting Zika nearly by half, U.S. and Brazilian re... […]
- Dengue immunity may buffer against Zika, study finds on February 7, 2019 at 11:28 am
In the epicenter of the Zika epidemic in northeast Brazil, 73 percent of people living in an urban slum in Salvador were infected in 2015, but a new study finds that those with immunity to dengue, a g... […]
- In some cases, getting dengue may protect against Zika on February 7, 2019 at 11:14 am
Previous infections with dengue virus may have protected some people in an urban slum in Brazil from getting Zika. In a study of more than 1,400 people in the Pau da Lima area of Salvador, those with ... […]
- Prior dengue infection protects against Zika on February 7, 2019 at 11:12 am
The higher a person's immunity to dengue virus, the lower their risk of Zika infection, an international team of scientists led by the University of Pittsburgh Graduate School of Public Health ... […]
- New antiviral may treat and prevent Zika infection on February 7, 2019 at 7:04 am
The Zika virus, which made headlines in 2016 following an outbreak in South America, is transmitted by mosquitos and can cause serious birth defects and neurological problems. Researchers are searchin... […]
- Zika ELISA Assays on February 7, 2019 at 3:57 am
This new series of Zika virus assays have little or no cross-reactivity with other flaviviruses. The Zika Virus NS1 ELISA assay is a highly sensitive and specific assay suitable for the quantitative d... […]
- Australian scientists work to put bite on mosquito-bourne Zika virus on February 6, 2019 at 10:06 pm
From genetically engineered mosquitoes to adapting bush medicine, Australian researchers are working on multiple fronts to prevent the arrival and spread of Zika virus in this country. Zika is a mosqu... […]
- Red-eyed mosquitoes engineered to break the chain of Zika virus transmission on February 6, 2019 at 9:53 pm
Scientists in Australia are looking at some pretty creative ways to tackle the Zika virus, which continues to pose a risk to millions across Africa, Asia and parts of the Americas. Following a ... […]
- Blocking Zika: New antiviral may treat and prevent infection, a Stanford study suggests on February 6, 2019 at 3:46 pm
A Stanford study shows Hsp70 protein inhibitors can protect mice from Zika virus without developing drug resistance, demonstrating their clinical potential. The Zika virus, which made headlines in 201... […]
via Bing News